利用缓释丁丙诺啡改善对刑事法律系统中阿片类药物使用障碍的护理。

IF 2.7 3区医学 Q2 PSYCHOLOGY, CLINICAL

American Journal of Drug and Alcohol Abuse Pub Date : 2024-10-09 DOI:10.1080/00952990.2024.2401980

Sean M Murphy

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Leveraging extended-release buprenorphine to improve care for opioid use disorder in the criminal-legal system.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

American Journal of Drug and Alcohol Abuse SUBSTANCE ABUSE-

CiteScore

4.70

自引率

3.70%

发文量

期刊介绍： The American Journal of Drug and Alcohol Abuse (AJDAA) is an international journal published six times per year and provides an important and stimulating venue for the exchange of ideas between the researchers working in diverse areas, including public policy, epidemiology, neurobiology, and the treatment of addictive disorders. AJDAA includes a wide range of translational research, covering preclinical and clinical aspects of the field. AJDAA covers these topics with focused data presentations and authoritative reviews of timely developments in our field. Manuscripts exploring addictions other than substance use disorders are encouraged. Reviews and Perspectives of emerging fields are given priority consideration. Areas of particular interest include: public health policy; novel research methodologies; human and animal pharmacology; human translational studies, including neuroimaging; pharmacological and behavioral treatments; new modalities of care; molecular and family genetic studies; medicinal use of substances traditionally considered substances of abuse.